News

Hamilton Lane Indices Now Accessible on Bloomberg Terminal

Hamilton Lane Indices Now Accessible on Bloomberg Terminal

Hamilton Lane Introduces New Indices on Bloomberg

Hamilton Lane, a leading global private markets investment firm, is thrilled to announce its innovative private markets indices are now integrated into the Bloomberg Terminal. This addition signifies a substantial enhancement for investors seeking comprehensive benchmarking for private equity, credit, and real assets fund performance.

Significant Industry Impact

This new suite of twenty private market closed-end fund performance indices on the Bloomberg Terminal and Data License offers investors vital data and analytical tools to effectively evaluate and compare fund performance. This strategic move also underscores Hamilton Lane's commitment to providing transparency and enhancing data access within the investment community.

Investment Robustness through Data

Hamilton Lane boasts an impressive $986 billion in assets under management, utilizing decades of proprietary data to develop aggregated and anonymized LP cash flow-driven indices. This extensive collection encompasses over 7,000 funds, now readily available on the Bloomberg Terminal, making it easier for investors to make informed decisions.

Enhancements Offered by the New Indices

The newly introduced indices provide various advantages for investors aiming to benchmark performance optimally:

  • Depth of Data – Investors can benchmark individual funds and portfolios, employing historical data dating back to 2000, which is derived from LP cash flows. This access allows for thorough analysis across strategies and sub-strategies.
  • Comprehensive Coverage – The indices cover all major private markets asset classes globally, including closed-end private equity, private credit, and private real assets, among others.
  • Performance Insights – Index-level returns can be accessed quarterly, supporting continued analysis and effective benchmarking.
  • Extended Insights – The indices complement the existing indices available in Bloomberg's private fund database, broadening the scope for performance analysis.
  • Interoperability – Linked to Financial Instrument Global Identifiers (FIGIs), facilitating easier integration into portfolio and risk management systems.
  • Data Scalability – Accessible via the Bloomberg Terminal or Bloomberg Data License, promoting scalable data operations across all investment strategies.

Addressing Investor Needs

Griff Norville, Head of Technology Solutions at Hamilton Lane, emphasized the significance of this launch, stating, "A growing set of investors are seeking greater clarity into private markets, and access to high-quality data is crucial for this transparency. By providing our indices on Bloomberg, we deliver a standardized view of performance that assists investors in making better-informed decisions within their workflows."

Collaboration with Bloomberg

Brad Foster, Head of Fixed Income & Private Markets at Bloomberg, commented on the collaboration, highlighting that "Hamilton Lane's indices are a strong complement to Bloomberg's private markets offerings, enhancing the depth of performance data accessible to our clients. We are dedicated to giving investors meaningful tools to evaluate and compare strategies confidently."

Further Enhancements to Bloomberg Services

The integration of Hamilton Lane's indices aligns with Bloomberg's continuous effort to support investors in screening for private funds, managing deal flow, analyzing risk, and tracking performance. These new additions significantly enhance Bloomberg's capacity to deliver relevant solutions that meet client needs in both public and private markets.

Hamilton Lane, with its over 30 years of dedicated focus on private markets investment, continues to lead the way in providing innovative solutions and insights to institutional and private wealth investors worldwide. This recent enhancement marks yet another step forward in their commitment to excellence in the investment sector.

Frequently Asked Questions

1. What are Hamilton Lane's new indices?

These are a suite of private market closed-end fund performance indices designed to help investors benchmark performance in various asset classes.

2. Where can investors access these indices?

Investors can find these indices on the Bloomberg Terminal, enhancing their ability to evaluate and compare fund performance.

3. How does this impact private market analysis?

The new indices improve transparency and provide robust data that enhances detailed performance analysis and strategy evaluation for investors.

4. What is the significance of the collaboration with Bloomberg?

This partnership makes Hamilton Lane's extensive benchmarking data widely accessible, significantly supporting investment professionals in their decision-making processes.

5. How does Hamilton Lane categorize its assets?

Hamilton Lane manages approximately $986 billion across discretionary and non-discretionary assets and provides a full spectrum of private markets strategies.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Skandia's Soundproofing Kit Expands to Brazil's Skies

Updated Category News Views 14

Soundproofing Takes Off in Brazil Skandia has just pulled off a neat trick, earning the nod from Brazil's National Civil Aviation Agency (ANAC) for their King Air soundproofing kit. That means quieter skies ahead for operators of the King Air 200 and 300 series in Brazil. This is no small feat, folks; it's like finally getting that coveted backstage pass after years of...

Continue Reading
Purina Institute Highlights Nutritional Science at WSAVA 2026

Updated Category News Views 19

A Global Stage for Pet Nutrition Science The folks over at the Purina Institute are back in the spotlight as they gear up to throw their weight behind the 51st World Small Animal Veterinary Association (WSAVA) Congress in Warsaw, Poland. Set for October 13-15, 2026, this isn’t just another event—they're bringing some serious clout with their 'Food for Thought'...

Continue Reading
IWP and VYRE Unveil 'The Plug' for VBNGtv Content

Updated Category News Views 21

Bringing Capital and Content Under One Roof There's something in the air as Itibari-Waynne & Partners (IWP) team up with the VYRE Network to crank out a fresh slate of content for VYRE Business News Global (VBNGtv). This partnership ain't just another splash in the buzzy world of digital media; it's like merging Wall Street with Hollywood. IWP, prepping to go full...

Continue Reading
Dentistry.One Achieves HITRUST i1, Boosts Cybertrust

Updated Category News Views 23

HITRUST i1 Certification: The Gold Standard in Security For a world increasingly reliant on digital infrastructure, cybersecurity certification is no longer just a badge of honor; it's a cornerstone of trust. Dentistry.One nailed this down by bagging that coveted HITRUST i1 certification. When folks talk about securing data, HITRUST might as well be speaking gospel. We're...

Continue Reading
Cala Launches Game-Changer Wearable for Tremor Relief

Updated Category News Views 13

Breaking New Ground in Neuromodulation Medical tech's on a roll, and Cala Health just hopped on the fast track with their latest launch—the Cala kIQ Plus System. This bad boy is aiming to offer relief for those grappling with hand tremors, thanks to its FDA clearance and a host of new features. It's the first of its kind, combining multiple therapy modes with an...

Continue Reading
Cure Blindness Project's 770K Screenings for World Sight Day

Updated Category News Views 24

Visionary Steps Toward a Brighter Future No two words could describe the task that Cure Blindness Project is tackling this year: vision and action. Marking World Sight Day on October 8, they plan to usher in 770,000 eye screenings across Asia, Africa, and the Caribbean. These initiatives aren't just numbers—they're a colossal step toward lifting the veil of avoidable...

Continue Reading
Northern Jet Names Veteran Matthew Harris as CEO

Updated Category News Views 34

Fresh Leadership at Northern Jet Well, if you didn’t see this coming, you’ve been snoozing on the tarmac. Northern Jet, no stranger to the skies after three decades, just roped in Matthew Harris as their new CEO from October 2, 2026. They're pulling in this hotshot with more than 25 years riding the turbulence of private aviation. And listen to this: his marching...

Continue Reading
Karoo Health Leaps Forward with New CCO Breton

Updated Category News Views 17

Change of Guard in Cardiac Health at Karoo Here's a move that might shake things up in the healthtech sector: Karoo Health just snagged Angela "Angie" Breton as their new Chief Commercial Officer. It's like putting a seasoned captain at the helm right before setting sail on uncharted waters. Breton's not just any captain—she's got a hefty 25 years of experience...

Continue Reading
NYSE Texas Redefines the U.S. Capital Markets Landscape

Updated Category News Views 21

NYSE Texas: Carving a Niche The notion of 'Y'all Street' might seem like a gimmick, but NYSE Texas is pushing a serious agenda with its newly released white paper, 'NYSE Texas and the Reshaping of U.S. Capital Markets.' This is no small feat. Texas is already housing 235 NYSE-listed companies, boasting a colossal combined worth of $4.8 trillion. With 130 of these firms...

Continue Reading
Truss Financial Tackles Home Equity Closing Delays

Updated Category News Views 24

Truss Financial Group's Bold Move Against Closing Delays In real estate, time is money. Even the most casual market observer could tell you delays can slice through a deal like a hot knife through butter. That's the headache home equity borrowers face, blindsided by closing delays that sneak up on them without warning. An Industry Bottleneck Finally Addressed Enter Truss...

Continue Reading

Top 5 Most Recently Viewed Articles

Eton Pharmaceuticals Celebrates Inclusion in Major Stock Indexes

Updated Category News Views 139

Eton Pharmaceuticals Marks a Significant Achievement in Stock Index Inclusion Eton Pharmaceuticals, Inc., a pioneering company specializing in treatments for rare diseases, has announced its addition to the renowned Russell 3000 and small-cap Russell 2000 Indexes. This notable milestone comes as part of the Russell Indexes' reconstitution, firmly establishing Eton in the...

Continue Reading
Richmond Mutual Bancorporation Declares New Quarterly Dividend

Updated Category News Views 103

Richmond Mutual Bancorporation Announces Exciting Dividend Richmond Mutual Bancorporation, Inc. (NASDAQ: RMBI) has officially shared the news that its Board of Directors has approved a cash dividend of $0.15 per share on its common stock. This action illuminates the stability and growth of the company, offering its stockholders a welcomed reward. Dividend Payment Schedule...

Continue Reading
Fulcrum Therapeutics: Advances in Sickle Cell Treatment and Finances

Updated Category News Views 163

Fulcrum Therapeutics Reports Positive Developments in Sickle Cell Disease Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a biotechnology company dedicated to developing innovative treatments for rare genetic diseases, has delivered some exciting updates and financial highlights recently. Notably, the company is making strides with its lead clinical program, pociredir,...

Continue Reading
KommuneKredit Reports Impressive H1 2024 Financial Results

Updated Category News Views 54

KommuneKredit Reports Strong Financial Results for H1 2024 Key Highlights • For the first half of 2024, KommuneKredit reported a pre-tax profit of 230 million DKK, an increase of 143 million DKK compared to the same period last year. • The net interest income for this period reached 336 million DKK, reflecting a growth of 145 million DKK compared to the first half of...

Continue Reading
Significant Decline in China's Foreign Direct Investment Figures

Updated Category News Views 92

China Sees a Sharp Decline in Foreign Direct Investment A recent report indicates that foreign direct investment (FDI) in China totaled 580.19 billion yuan, or about $81.80 billion, from January to August of this year. This marks a considerable decline of 31.5% compared to the same period last year, according to the Chinese commerce ministry. Analysis of Investment Trends...

Continue Reading